A56.8
Sexually transmitted chlamydial infection of other sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Chlamydial infections are caused by the bacteria *Chlamydia trachomatis* and are among the most common sexually transmitted infections worldwide. While they frequently affect the genital areas, these bacteria can also infect other parts of the body, resulting in what is classified as 'Sexually transmitted chlamydial infection of other sites' under ICD-10 code A56.8. This condition involves infection at locations outside the typical genital areas, such as the rectum, throat, or eyes, which can occur through various forms of sexual contact. Recognizing these less common infection sites is important for appropriate diagnosis and management.
Causes & Symptoms
Clinical Causes: Unprotected anal or oral sex leading to bacteria transmission to the rectum or throat Sharing contaminated sexual devices or engaging in sexual behaviors involving contact with infected areas Autoinoculation from infected genital sites to other body parts Perinatal transmission during childbirth
Key Symptoms: Rectal infections may cause pain, discharge, bleeding, or discomfort during bowel movements Throat infections often are asymptomatic but may cause sore throat or mild throat discomfort Eye infections (conjunctivitis) can result in redness, discharge, and irritation Some individuals remain asymptomatic, making detection challenging
Diagnostic & Treatment
Diagnosis Path: Diagnosing chlamydial infections at uncommon sites typically involves a combination of patient history, physical examination, and laboratory testing. Tests include nucleic acid amplification tests (NAATs), which are highly sensitive and specific. Samples for testing might be collected from the rectum, throat, or eyes depending on the suspected infection site. Due to the often asymptomatic nature of these infections, screening in at-risk populations is crucial for early detection.
Treatment Protocols: Treatment generally involves a course of antibiotics effective against *Chlamydia trachomatis*, such as azithromycin or doxycycline. The choice of medication depends on the infection site and patient-specific factors. It is important to treat all sexual partners concurrently to prevent re-infection. Follow-up testing may be recommended to confirm the eradication of the bacteria. Additionally, abstaining from sexual activity during treatment and until completion of therapy is advised to avoid spreading the infection.
Clinical Advice & FAQs
Billing Guidance
Is A56.8 a billable ICD-10 code?
Yes, A56.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A56.8?
Clinical documentation must specify the nature of Sexually transmitted chlamydial infection of other sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference